Catalyst Wire Dossier Catalyst Wire Dossier

XOFLUZA

baloxavir marboxil · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for XOFLUZA, covering 2018-10-24 to 2026-07-02. Get the full timeline:

Most recent: EMA Authorised: Xofluza (Baloxavir marboxil) — Roche Registration GmbH

See pricing